ACTIONS > Recherche clinique > Publications et communications

Publications en tant qu’auteurs

1.    Allach El Khattabi L, Brun S, Gueguen P, Chatron N, Guichoux E, Schutz S, Nectoux J, Sorlin A, Quere M, Boudjarane J, Tsatsaris V, Mandelbrot L, Schluth-Bolard C, Dupont JM, Rooryck C; H+ Consortium. Performance of Semiconductor sequencing platform for non-invasive prenatal genetic screening for fetal aneuploidies: results from a multicenter prospective cohort study in a clinical setting. Ultrasound Obstet Gynecol. 2018 Septembre 6.

2.    Allaire M, Nahon P, Layese R, Bourcier V, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki JP, Zarski JP, Riachi G, Calès P, Péron JM, Alric L, Bourlière M, Mathurin P, Blanc JF, Abergel A, Serfaty L, Mallat A, Grangé JD, Attali P, Bacq Y, Wartelle C, Dao T, Thabut D, Pilette C, Silvain C, Christidis C, Nguyen-Khac E, Bernard-Chabert B, Zucman D, Di Martino V, Sutton A, Letouzé E, Audureau E, Roudot-Thoraval F; ANRS CO12 CirVir group. Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradication. Hepatology. 2018 Oct. 68(4):1245-1259.

3.    Arikawa S, Rollins N, Jourdain G, Humphrey J, Kourtis AP, Hoffman I, Essex M, Farley T, Coovadia HM, Gray G, Kuhn L, Shapiro R, Leroy V, Bollinger RC, Onyango-Makumbi C, Lockman S, Marquez C, Doherty T, Dabis F, Mandelbrot L, Le Coeur S, Rolland M, Joly P, Newell ML, Becquet R. Contribution of Maternal Antiretroviral Therapy and Breastfeeding to 24-Month Survival in Human Immunodeficiency Virus-Exposed Uninfected Children: An Individual Pooled Analysis of African and Asian Studies. Clin Infect Dis. 2018 Mai 17. 66(11):1668-1677.

4.    Benhammou V, Tubiana R, Matheron S, Sellier P, Mandelbrot L, Chenadec JL, Marel E, Khoshnood B, Warszawski J, ANRS CO1/CO11-EPF French Perinatal Cohort study group           .HBV or HCV Coinfection in HIV-1-Infected Pregnant Women in France: Prevalence and Pregnancy Outcomes. J Acquir Immune Defic Syndr. 2018 Avril 15. 77(5):439-450.

5.    Billa O, Chalouni M, Salmon D, Poizot-Martin I, Gilbert C, Katlama C, Neau D, Chas J, Morlat P, Lacombe K, Naqvi A, Barange K, Gervais A, Bouchaud O, Rosenthal E, Lascoux-Combe C, Garipuy D, Alric L, Dominguez S, Vittecoq D, Goujard C, Duvivier C, Aumaitre H, Miailhes P, Zucman D, Simon A, Lazaro E, Raffi F, Esterle L, Wittkop L, Bani-Sadr F; ANRS CO13 HEPAVIH Study Group. Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients- ANRS-CO13 HEPAVIH cohort. PLoS One. 2018 Dec 18. 13(12):e0208657.

6.    Cacoub P, Nahon P, Layese R, Blaise L, Desbois AC, Bourcier V, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki JP, Zarski JP, Riachi G, Calès P, Péron JM, Alric L, Bourlière M, Mathurin P, Blanc JF, Abergel A, Serfaty L, Mallat A, Grangé JD, Attali P, Bacq Y, Wartelle C, Dao T, Thabut D, Pilette C, Silvain C, Christidis C, Capron D, Thiefin G, Zucman D, Di Martino V, Bagnis CI, Ziol M, Sutton A, Letouze E, Roudot-Thoraval F, Audureau E; ANRS CO12 CirVir group. Prognostic value of viral eradication for major adverse cardiovascular events in hepatitis C cirrhotic patients          Am Heart J. 2018 Apr. 198:4-17.

7.    Claireaux M, Galperin M, Benati D, Nouël A, Mukhopadhyay M, Klingler J, de Truchis P, Zucman D, Hendou S, Boufassa F, Moog C, Lambotte O, Chakrabarti LA. A High Frequency of HIV-Specific Circulating Follicular Helper T Cells Is Associated with Preserved Memory B Cell Responses in HIV Controllers. Mbio. 2018 May 8. 9(3).

8.    Costentin C, Layese R, Bourcier V, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki JP, Zarski JP, Riachi G, Calès P, Péron JM, Alric L, Bourlière M, Mathurin P, Blanc JF, Abergel A, Serfaty L, Mallat A, Grangé JD, Attali P, Bacq Y, Wartelle C, Dao T, Thabut D, Pilette C, Silvain C, Christidis C, Nguyen-Khac E, Bernard-Chabert B, Zucman D, Di Martino V, Sutton A, Letouzé E, Imbeaud S, Zucman-Rossi J, Audureau E, Roudot-Thoraval F, Nahon P; ANRS CO12 CirVir group. Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study. Gastroenterology. 2018 Aug. 155(2):431-442.

9.    Coupaye M, Legardeur H, Sami O, Calabrese D, Mandelbrot L, Ledoux S       Impact of Roux-en-Y gastric bypass and sleeve gastrectomy on fetal growth and relationship with maternal nutritional status. Surg Obes Relat Dis. 2018 Octobre. 14(10):1488-1494.

10.  Dussaux C, Senat MV, Bouchghoul H, Benachi A, Mandelbrot L, Kayem G    .Preterm premature rupture of membranes: is home care acceptable?. J Matern Fetal Neonatal Med. 2018 Septembre. 31(17):2284-2292.

11.  Droz N, Chaleard J, Laurent M, Mandelbrot L, Cojocaru B. Newborn consultations in paediatric emergency departments. Soins Pediatr Pueric. 2018 Juillet –Aout. 39(303):32-37.

12.  Egloff C, Eldin de Pecoulas A, Mechler C, Tassin M, Mairovitz V, Corrizi F, Dussaux C, Boutron A, Simon I, Guet A, Sibiude J, Mandelbrot L, Picone O. Prenatal sonographic description of fetuses affected by pyruvate dehydrogenase or pyruvate carboxylase deficiency. Prenatal diagnosis. 2018 Mai 12.

13.  Farfour E, Lesprit P, Chan Hew Wai A, Mazaux L, Fourn E, Majerholc C, Bonan B, Vasse M, Zucman D         . Acute hepatitis A breakthrough in MSM in Paris area: implementation of targeted hepatitis A virus vaccine in a context of vaccine shortage. AIDS. 2018 Feb 20. 32(4):531-532.

14.  Faure-Bardon V, Mandelbrot L, Duro D, Dussaux C, Le M, Peytavin G. Placental transfer of elvitegravir and cobicistat in an ex-vivo human cotyledon double perfusion model. AIDS. 2018 Janvier 28. 32(3):321-325.

15.  Hanachi M, Bohem V, Bemer P, Kayser N, de Truchis P, Melchior JC  . Negative role of malnutrition in cell-mediated immune response: Pneumocystis jirovecii pneumonia (PCP) in a severely malnourished, HIV-negative patient with anorexia nervosa. Clin Nutr ESPEN. 2018 Juin. 25:163-165.

16.  Hussenet C, Calin R, Boussouar S, Londner C, Caby F, Tubiana R, Pourcher V. Chylothorax as a complication of Kaposi's sarcoma in an AIDS patient. Med Mal Infect. 2018 Feb. 48(1):66-69.

17.  Kayem G, Doloy A, Schmitz T, Chitrit Y, Bouhanna P, Carbonne B, Jouannic JM, Mandelbrot L, Benachi A, Azria E, Maillard F, Fenollar F, Poyart C, Bebear C, Goffinet F. Antibiotics for amniotic-fluid colonization by Ureaplasma and/or Mycoplasma spp. to prevent preterm birth: A randomized trial. Plos One. 2018 Novembre 7. 13(11):e0206290.

18.  Khediri Z, Vauloup-Fellous C, Benachi A, Ayoubi JM, Mandelbrot L, Picone O. Adverse effects of maternal enterovirus infection on the pregnancy outcome: a prospective and retrospective pilot study. Virol J. 2018 Avril 16. 15(1):70.

19.  de Laroche M, Pelissier G, Noêl S, Rouveix E. Occupational and non-occupational exporsure to viral risk. Rev Med Interne. 2018 Octobre 5. 40(4):238-245.

20.  Law-Ye B, Carlier RY, Richard R, Blanc R, Jourdan C, de Truchis P, Viry F, Dormont D, Leclercq D, Clarençon F. Considerations on the Relevance of Cerebral Fusiform Aneurysms Observed During HIV Infection. Clin Neuroradiol. 2018 Septembre. 28(3):357-365.

21.  Leblanc J, Hejblum G, Costagliola D, Durand-Zaleski I, Lert F, de Truchis P, Verbeke G, Rousseau A, Piquet H, Simon F, Pateron D, Simon T, Crémieux AC; DICI-VIH (Dépistage Infirmier CIblé du VIH) Group. Targeted HIV Screening in Eight Emergency Departments: The DICI-VIH Cluster-Randomized Two-Period Crossover Trial. Ann Emerg Med. 2018 Juillet 2. 72(1):41-53.

22.  Linard M, Blondel B, Estellat C, Deneux-Tharaux C, Luton D, Oury JF, Schmitz T, Mandelbrot L, Azria E; PreCARE study group.Association between inadequate antenatal care utilisation and severe perinatal and maternal morbidity: an analysis in the PreCARE cohort. BJOG. 2018 Avril. 125(5):587-595.

23.  Makinson A, Hayot M, Eymard-Duvernay S, Ribet C, Raffi F, Pialoux G, Zucman D, Poizot-Martin I, Bonnet F, Abgrall S, Tattevin P, Cheret A, Ferry T, Mauboussin JM, Marchand L, Rouzaud C, Reynes J, Zins M, Le Moing V; ANRS EP48 HIV CHEST study Team    . HIV is associated with airway obstruction: a matched controlled study. AIDS. 2018 Jan 14. ;32(2):227-232.

24.  Mandelbrot L, Kieffer F, Sitta R, Laurichesse-Delmas H, Winer N, Mesnard L,Berrebi A, Le Bouar G, Bory JP, Cordier AG, Ville Y, Perrotin F, Jouannic JM, Biquard F, d'Ercole C, Houfflin-Debarge V, Villena I, Thiébaut R; TOXOGEST Study Group. Prenatal therapy with pyrimethamine + sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: a multicenter, randomized trial. Am J Obstet Gynecol. 2018 Octobre. 219(4):386.

25.  Melliez H, Mary-Krause M, Bocket L, Guiguet M, Abgrall S, De Truchis P, Katlama C, Martin-Blondel G, Henn A, Revest M, Robineau O, Khuong-Josses MA, Canestri A, De Castro N, Joly V, Mokhtari S, Risso K, Gasnault J, Costagliola D; French Hospital Database on HIV (ANRS-C4). Risk of Progressive Multifocal Leukoencephalopathy in the Combination Antiretroviral Therapy Era in the French Hospital Database on Human Immunodeficiency Virus (ANRS-C4). Clin Infect Dis. 2018 Juillet 2. 67(2):275-282.

26.  Mercié P, Arsandaux J, Katlama C, Ferret S, Beuscart A, Spadone C, Duvivier C, Reynes J, Wirth N, Moinot L, Bénard A, Zucman D, Duval X, Molina JM, Spire B, Fagard C, Chêne G; ANRS 144 Inter-ACTIV study group. Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial. Lancet HIV. 2018 Mar. 5(3):e126-e135.

27.  de Monteynard LA, Matheron S, Grabar S, de Truchis P, Gilquin J, Pavie J, Launay O, Meynard JL, Khuong-Josses MA, Rey D, Mahamat A, Dray-Spira R, Simon A, Costagliola D, Abgrall S; FHDH-ANRS CO4           . Influence of geographic origin on AIDS and serious non-AIDS morbidity/mortality during cART among heterosexual HIV-infected men and women in France. PLoS One. 2018 Octobre 31. 19(1):590.

28.  Nahon P, Layese R, Bourcier V, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki JP, Zarski JP, Riachi G, Calès P, Péron JM, Alric L, Bourlière M, Mathurin P, Blanc JF, Abergel A, Serfaty L, Mallat A, Grangé JD, Attali P, Bacq Y, Wartelle C, Dao T, Thabut D, Pilette C, Silvain C, Christidis C, Nguyen-Khac E, Bernard-Chabert B, Zucman D, Di Martino V, Sutton A, Roudot-Thoraval F, Audureau E; ANRS CO12 CirVir Group. Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs. Gastroenterology. 2018 Nov. 155(5):1436-1450.

29.  Nguyen T, Akhavan S, Caby F, Bonyhay L, Larrouy L, Gervais A, Lebray P, Poynard T, Calmus Y, Simon A, Valantin MA, Calvez V, Marcelin AG, Todesco E. Net emergence of substitutions at position 28 in NS5A of hepatitis C virus genotype 4 in patients failing direct-acting antivirals detected by next-generation sequencing. Epub. 2018 Sep 17.

30.  Peyronnet V, Sibiude J, Mandelbrot L, Kayem G          Impact of the detection of small for gestational age fetuses on the neonatal prognosis     Gynecol Obstet Fertil Senol. 2018 Fevrier. 46(2):71-77.

31.  Plainvert C, El Alaoui F, Tazi A, Joubrel C, Anselem O, Ballon M, Frigo A, Branger C, Mandelbrot L, Goffinet F, Poyart C. .Intrapartum group B Streptococcus screening in the labor ward by Xpert® GBS real-time PCR. Eur J Clin Microbiol Infect Dis. 2018 Fevrier. 37(2):265-270.

32.  Rosenthal E, Fougerou-Leurent C, Renault A, Carrieri MP, Marcellin F, Garraffo R, Teicher E, Aumaitre H, Lacombe K, Bailly F, Billaud E, Chevaliez S, Dominguez S, Valantin MA, Reynes J, Naqvi A, Cotte L, Metivier S, Leroy V, Dupon M, Allegre T, De Truchis P, Jeantils V, Chas J, Salmon-Ceron D, Morlat P, Neau D, Perré P, Piroth L, Pol S, Bourlière M, Pageaux GP, Alric L, Zucman D, Girard PM, Poizot-Martin I, Yazdanpanah Y, Raffi F, Pabic EL, Tual C, Pailhé A, Amri I, Bellissant E, Molina JM; ANRS HC31 SOFTRIH Study Group. Efficacy, safety and patient-reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor-experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study). HIV Med. 2018 Mar. 19(3):227-237.

33.  Roul H, Mary-Krause M, Ghosn J, Delaugerre C, Pialoux G, Cuzin L, Launay O, Lacombe JM, Menard A, De Truchis P, Delfraissy JF, Weiss L, Costagliola D; FHDH-ANRS CO4. CD4+ cell count recovery after combined antiretroviral therapy in the modern combined antiretroviral therapy era. AIDS. 2018 Novembre 13. 32(17):2605-2614.

34.  Seang S, Schneider L, Nguyen T, Lê MP, Soulie C, Calin R, Caby F, Valantin MA, Tubiana R, Assoumou L, Marcelin AG, Peytavin G, Katlama C. Darunavir/ritonavir monotherapy at a low dose (600/100 mg/day) in HIV-1-infected individuals with suppressed HIV viraemia.          J Antimicrob Chemother. 2018 Feb. 73(2):490-493.

35.  Warszawski J, Thomas C, Dialla O, Garrait V, Dollfus C, Reliquet V, Clech L, Dert C, Mandelbrot L, Audrain M, Blanche S; ANRS EPF Study Group       .T-Cell Receptor Excision Circles in HIV-Exposed, Uninfected Newborns Measured During a National Newborn Screening Program for Severe Combined Immunodeficiency. J PEDIATR. 2018 Novembre. 202:311-314.

36.  Zucman D, Mellot F, Couderc L. HIV-Associated Cancers and Related Diseases. N Engl J Med. 2018 May 31. 378(22):2144-5.

Publications en tant que collaborateurs

1.    Banigé M, Polak M, Luton D; Research Group for Perinatal Dysthyroidism (RGPD). Prediction of Neonatal Hyperthyroidism. J PEDIATR. 2018 Juin. 197:249-254.

2.    Darlington M, Carbonne B, Mailloux A, Brossard Y, Levy-Mozziconacci A, Cortey A, Maoulida H, Simon T, Rousseau A, Durand-Zaleski I; GENIFERH1 Study Group. Effectiveness and costs of non-invasive foetal RHD genotyping in rhesus-D negative mothers: a French multicentric two-arm study of 850 women. BMC pregnancy childbirth. 2018 Decembre 4. 18(1):496.

3.    Lê MP, Chaix ML, Chevret S, Bertrand J, Raffi F, Gallien S, El Abbassi EMB, Katlama C, Delobel P, Yazdanpanah Y, Saillard J, Molina JM, Peytavin G; ANRS 165 DARULIGHT Study Group. Pharmacokinetic modelling of darunavir/ritonavir dose reduction (800/100 to 400/100 mg once daily) in a darunavir/ritonavir-containing regimen in virologically suppressed HIV-infected patients: ANRS 165 DARULIGHT sub-study. J Antimicrob Chemother. 2018 Août 1. 73(8):2120-2128.

4.    Meynard JL, Moinot L, Landman R, Morand-Joubert L, Besseghir A, Kolta S, Sphire B, Todesco E, Bouchaud , Fagard C, Chene G, Ghirard PM, ANRS 140 DREAM Study Group        . Week 96 efficacy of lopinavir/ritonavir monotherapy in virologically suppressed patients with HIV: a randomized non-inferiority trial (ANRS 140 DREAM). J Antimicrobial Chemotherapy. 2018 Juin 1. 73(6):1672-1676.

5.    Molina JM, Gallien S, Chaix ML, El Abbassi EM, Madelaine I, Katlama C, Valin N, Delobel P, Desseaux K, Peytavin G, Saillard J, Raffi F, Chevret S; ANRS 165 Darulight Study Group. Low-dose ritonavir-boosted darunavir in virologically suppressed HIV-1-infected adults: an open-label trial (ANRS 165 Darulight). J Antimicrob Chemother. 2018 Août 1. 73(8):2129-2136.

6.    Nordmann S, Vilotitch A, Roux P, Esterle L, Spire B, Marcellin F, Salmon-Ceron D, Dabis F, Chas J, Rey D, Wittkop L, Sogni P, Carrieri P; ANRS CO13 HEPAVIH Study Group. Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus-co-infected patients (ANRS CO13-HEPAVIH). J Viral Hepat. 2018 Feb. 25(2):171-179.

7.    Pressiat C, Hirt D, Treluyer JM, Zheng Y, Morlat P, Naqvi A, Tran L, Viard JP, Avettand-Fenoel V, Rouzioux C, Meyer L, Cheret A; OPTIPRIM Study Group. Decreased darunavir concentrations during once-daily co-administration with maraviroc and raltegravir: OPTIPRIM-ANRS 147 trial. J Antimicrob Chemother. 2018 Jan 22.

8.    Raymond S, Nicot F, Pallier C, Bellecave P, Maillard A, Trabaud MA, Morand-Joubert L, Rodallec A, Amiel C, Mourez T, Bocket L, Beby-Defaux A, Bouvier-Alias M, Lambert-Niclot S, Charpentier C, Malve B, Mirand A, Dina J, Le Guillou-Guillemette H, Marque-Juillet S, Signori-Schmuck A, Barin F, Si-Mohamed A, Avettand Fenoel V, Roussel C, Calvez V, Saune K, Marcelin AG, Rodriguez C, Descamps D, Izopet J; French National Agency for Research on AIDS and Viral Hepatitis (ANRS) AC11 Resistance Study Group. Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen. Clin Infect Dis. 2018 May 2. 66(10):1588-1594.

9.    Roux P, Marcellin F, Ndiaye K, Suzan-Monti M, Mayet A, Duracinsky M, Briand-Madrid L, Marandan G, Mora M, Préau M, Verger P, Carrieri P, Dray-Spira R, SpireB, ANRS-VESPA2 Study Group. Posttraumatic Stress Discorder as a Significant Correlate of Voluntary Antiretroviral Treatment Interruption in Adult HIV-Infected Patients Followed up in French Hospitals: Dat From the ANRS-VESPA2 National Survey. Journal of clinical psychiatry. 2018 Mai/Juin. 79(3).

10.  Suzan-Monti M, Celse M, Vilotitch A, Demoulin B, Dray-Spira R, Yéni P, Lert F, Spire B; ANRS VESPA2 study group. Assessement of Awareness of, Concerns and Attitudes Towards HIV-Related Court-Case Sentences in France in a Representative Sample of People Living with HIV (ANRS VESPA2 Survey). AIDS Behav. 2018 Oct. 22(10):3264-3272.

11.  de Truchis P, Assoumou L, Landman R, Mathez D, Le Dû D, Bellet J, Amat K, Katlama C, Gras G, Bouchaud O, Duracinsky M, Abe E, Alvarez JC, Izopet J, Saillard J, Melchior JC, Leibowitch J, Costagliola D, Girard PM, Perronne C; ANRS 162-4D Study Group. Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial.   J Antimicrob Chemother. 2018 Mars 1. 73(3):738-747.

12.  Unal G1,2, Alessandri-Gradt E1, Leoz M1, Pavie J3, Lefèvre C1, Panjo H2, Charpentier C4, Descamps D4, Barin F5, Simon F6, Meyer L2,7, Plantier JC1; ORIVAO Study: Collaborators (207)Chennebault J, Fialaire P, Le Guillou-Guillemette H, Rehaiem S, Chanzy B, Clavere G, Gaillat J, Courdavault L, Genet P, Gerbe J, Benoit C, Honore Bouakline S, Waldner A, Bettinger D, Chirouze C, Bernard N, Reigadas S, Dupont X, Gaillard JL, Gault E, Reimann E, Otterbein G, Thomas L, Vaghefi P, Benoit M, Buthiot N, Goux A, Chambrin V, Deback C, Fior R, Raho Moussa M, Antoniotti O, Coban D, Cormerais L, Henquell C, Jacomet C, Lesens O, Chanoine N, Villmant A, Van Autreve JL, Bloch M, Ichou H, Manceron V, Mortier E, Zeng A, Bouvier-Alias M, Dominguez S, Lascaux-Cametez AS, Lelievre JD, Levy Y, Melica-Gregoire G, Pawlotsky JM, Pothier P, Waldner A, Inchiappa L, Verhaeghe A, Olivier B, Pathe JP, Berthe H, Mathez D, Favret V, Troisvallets D, Vandemeulebroucke E, Ceccaldi J, El Harif Z, Bocket L, Barbut P, Chaix F, Lambert C, Lambolez T, Miatezila J, Son O, Brunet P, Chappe C, Dhiver C, Lecomte V, Meddeb L, Poizot-Martin I, Tamalet C, Valadier J, Beck-Wirth G, Benomar M, Delarbre JM, Peter JM, Bevilacqua S, Venard V, Daneluzzi V, Idri N, Montoya B, Ferre V, Garnier E, Hue H, Larmet L, Point P, Raffi F, Reliqiet V, Rodallec A, Secher S, Amoyel P, Botton E, Janowski M, Le Cocguic Y, Deleplanque P, Descamps JM, Lapine M, Sunder S, Chansombat M, Charpentier C, Damond F, Diallo B, Duval X, Julia Z, Landman R, Legac S, Rioux C, Yeni P, Krivine A, Blanche P, Cros A, Gazalet P, Ghosn J, Krivine A, Sobel A, Bercot B, Diemer M, Parrinello M, Bey Boumezrag C, Bodard L, Gibert S, Huche FX, Raffenne L, Strebler M, Blanc C, Bourzam E, Hansel B, Lupin C, Wirden M, Bourzam E, Collias L, Effa J, Jung C, Pavie J, Pere H, Si Mohamed A, Delaugerre C, Gerard L, Loze B, Maylin S, Nabias R, Ponscarme D, Deleuze J, Rozenberg F, Bachour B, Bani-Sadr F, Chas J, Hamidi M, Kherallah L, Le Nagat S, Le Pendeven C, Moreau F, Nicolas JC, Schneider V, Tabone MD, Vaudre G, Giraudeau G, Le Moal G, Plainchamp D, Blondin G, Dorval I, Duthe JC, Perfezou P, Berger JL, Brodard V, Kmiec I, Rouger C, Strady C, Chappelin JM, Maillard A, Ratajczak M, Debab Y, De Oliveira F, Depatureaux A, Gueit I, Lemee V, Theron D, Pasdeloup I, Camps P, Bigaillon C, Ficko C, Imbert C, Rapp C, Grand C, Michau C, Bornarel D, Devillier P, Farfour E, Majerholc C, Vignon D, Zucman D, El Addouli M, Danjoux MF, Journe J, Leveneur Y, Marchou B, Nicot F, Prevoteau Du Clary F, Bonne S. Human Immunodeficiency Virus Type 1 Group O Infection in France: Clinical Features and Immunovirological Response to Antiretrovirals. Clin Infect Dis. 2018 May 17. 66(11):1785-1793.

Communications orales

1.    Azizi L, Plassart F. PVVIH et troubles neurocognitifs : Sont-ils toujours aussi présents ? Comment les évaluer ?  Conduite à tenir et suivi ? 8e Rencontres infirmières Gilead. 21 et 22 septembre 2018,      Marseille, France.

2.    C Courtin, ML Eynard, A Greder-Belan, C Fortin, F. Samdjee. Education thérapeutique du patient… et si c’était un préparateur ? 40ème congrès de Pharmacie Hospitalière. Congrès APHF (Association de Pharmacie Hospitalière de l’Ile de France). 2018 11 29-30         , Paris France.

3.    Papot E, GerbeJ, Valantin MA, Brun A, Hamet G, Mackoumbou C, Deschaud M, Marcou M, Fonquernie L, Bouvet E, Rouveix E, Rozenbaum W, Collectif Idf Centre (R. Agher, P. Louasse, M. Hamidi, C. Blanc), Alain Sobel, Collectif Idf Sud (Agnes Cros, Marie-Pierre Pietri), Christine KATLAMA. Infections VIH et co-infections VHC et VHB en Ile-de-France en 2016 : expérience des 5 CoreVIH. AFRAVIH 2018. 4 - 7 avril 2018, Bordeaux, France.

4.    de Truchis P, Delaugerre C, Corbeau P. L'Allègement en 3 questions médicales. 19ème congrès de la SFLS. 2018 Octobre 11 ; Reims, France.

5.    Zucman D, Dimi S, Dreyfus JF, Farfour E        . Diminution de l’incidence de la syphilis latente chez les HSH VIH positifs de la région parisienne: résultats préliminaires de l’étude ANRS DRIVER AFRAVIH2018-LB-2155            AFRAVIH 2018. Avril 2018, Bordeaux, France.

Posters

1.    Benamar F, Gerbe J, Caby F, Azizi L, Wifak-Moukrim B, Genet P, Plassart F, Pons JL. Knowledge regarding human deficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) in a french hospital. ISHEID. 16-18 may 2018, Marseille, France.

2.    Caby F, Grabar S, on behalf of the CD4/CD8 Ratio and Cancer Working Group of the COHERE in EuroCoord. CD4/CD8 ratio and risk of Kaposi sarcoma in people living with HIV achieving suppressed viraemia on antiretroviral therapy. IWHOD 2018 (International Workshop on HIV and Hepatitis Observatinal Databases). 22-24 mars 2018, Fuengirola, Espagne

3.    Caby F, Grabar S, on behalf of the CD4/CD8 Ratio and Cancer Working Group of the COHERE in EuroCoord. CD4/CD8 ratio and risk of Kaposi sarcoma and non-Hodgkin lymphoma in people living with HIV achieving suppressed viraemia on antiretroviral therapy. 22nd International AIDS Conference (AIDS 2018). 23-27 juillet 2018, Amsterdam, Pays Bas.

4.    Charpentier C, Dimi S, Albucher D, Zucman D. Comment mettre en œuvre la stratégie nationale de santé sexuelle ?. 19ème JNI. 2018 Juin, Nantes, France.

5.    Claireaux M, Robinot R, Staropoli I, Brelot A, Hery M, Patgaonkar M, Nouel A, Volant S, Perthame E, Boufassa F, Zucman D, de Truchis P, Lambotte O, Chakrabarti LA. Low CCR5 Expression Protects Specific CD4+ T Cells of HIV Controllers From Viral Entry. HIV4P. 2018 Octobre, Madrid, Espagne.

6.    Claireaux M, Galperin M, Benati B, Nouel A, Mukhopadhyay M, de Truchis P, Zucman D, Hendou S, Boufassa F, Lambotte O. Specific ctfh frequency correlates with memory b cell responses in Hiv controllers. CROI 2018. 2018 Mars, Boston, Etats-Unis.

7.    C Courtin, ML Eynard, A Greder-Belan, C Fortin, F. Samdjee, Education thérapeutique du patient… et si c’était un préparateur ? 40ème congrès de Pharmacie Hospitalière. Congrès APHF (Association de Pharmacie Hospitalière de l’Ile de France). Novembre 2018, Paris France.

8.    Duracinsky M, Dimi S, Chassany O, Carrieri P, Villes V, Timsit J, Fouéré S, Zucman D. Asymptomatic Sexually Transmitted Infections in French HIV MSM a predictive risk score for screening - ANRS DRIVER study. HIV 18. 2018 Octobre, Glasgow, Ecosse.

9.    Duracinsky M, Thonon F, Lert F, Lalanne C, Zucman D, Sogni P, Leluong T, Joseph O, Roudot-Thoraval F, Normand I, Chassany O. A new strategy for screening for infectious diseases amongst migrants: the STRADA study. 1st world congress on migration, ethnicity, race and health. 2018 Mai, Edinburgh, Ecosse.

10.  Duracinsky M, Dimi S, Piroth L, Thonon F, Zucman D, Chassany O, Carrieri P. La précarité sociale dans la population française de VIH est fréquente et liée à l'anxiété, à la dépression et la dégradation de la qualité de vie. Résultats de l'étude électronique EQUIPIER. 19ème JNI. 2018 Juin, Nantes, France.

11.  Duracinsky M, Carrieri P, Lalanne C, Zucman D, Chassany O, Weiss L, Duvivier C. Consommation de substances et comportement sexuel à risque chez les PVVIH en France: résultats de l'étude EQUIPIER. 19ème JNI. 2018 Juin, Nantes, France.

12.  Force G, Ghout I, Bouaziz-Amar E, Dorgham K, Marigot-Outtandy D, Troisvallet D, Hahn V, Defferrière H, Darchy N, Ropers J, Laplanche JL, Delaugerre C, Peytavin G, Carcelain G, de Truchis P. HAND Improvement is Associated with Increase CPE score After ARV Intensification-Neuro+3 Study. CROI. 2018 Mars, Paris, France.

13.  Fouéré S, Timsit J, Lalanne C, Duracinsky M, Chassany O, Majerholc C, Fourn E, Zucman D, Farfour E, Dimi S. Diminution de la fréquence de la syphilis chez les MSM VIH : résultats des deux phases d’inclusion de l’Etude DRIVER. 19ème JNI. 2018 Juin, Nantes, France.

14.  Gerbe J, Lepinay H, Akpan T, Bornarel D, Daneluzzi V, Laurichesse JJ, Montoya B, Mortier E, de Laroche M, Souak s, Rouveix E, de Truchis P. Analyse descriptive des patients VIH co-infectés VHC suivis sur le territoire du Corevih IDF ouest. SFLS. 2018 Octobre, Reims, France.

15.  Grabar S, Selinger-Leneman H, Abramovitz L, Boue F, Mary-Krause M, Duvivier C, Rouveix E, Poizot-Martin I, Costagliola D. Anal cancer risk and use of protease inhibitor. A nested case-control study within the ANRS CO4-FHDH cohort. HIV DRUG THERAPY. 2018 Octobre 28, Glasgow, UK.

16.  Meynard JL, Duvivier C, Molina JM, Ajana F, Pichancourt G, Morlat P, Revest M, Poizot-Martin I, Hocqueloux L, Janssen C, Genet P, Katlama C, Leclercq P,  Haubrich R, Durand F, Sahali S. First real world data of tenofovir alafenamide-based ART in adult HIV-1-infected patients enrolled in the French TARANIS cohort: results on the use of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF). HIV Drug Therapy Glasgow. 28-31 October 2018, Glasgow, UK.

17.  Moussa-Saley S, Madougou B, Lolom I, Mamane D, de Truhis P, Adehossi E, Rouveix E, Bouvet E   . Prévention du risque de transmission de la tuberculose à l'Hôpital National de Niamey (HNN), Niger: apport du GeneXpert dans le diagnostic de la tuberculose pulmonaire (TP) et la reconnaissance des patients justifiant d'un traitement et des mesures d'isolement respiratoire. AFRAVIH. 2018 Avril 04, Bordeaux, France.

18.  Nigon H, Djebbar R, Beauchet A, De Laroche M, Freire Maresca A, Lachatre M, Greffe S, Roux A-L, Moreau F, Gault E, Rouveix E. Pratiques de réalisation des sérologies VHC et syphilis dans un CEGIDD de la région parisienne. Congrès national de la SFLS. 2018 Octobre 11, Reims, France.

19.  Nounou Y, Moussa-Saley S, Daou M, Saidou M, Hassane H, Yahayé H, Lolom I, Néré ML, Rouveix E, Delaugerre C, de Truchis P. Efficacité des traitements ARV de deuxième ligne et évaluation de la résistance génotypique en pratique courante au Niger. AFRAVIH. 2018 Avril 04, Bordeaux, France.

20.  Piron P, Freire-Maresca A, Shelly M, Cabral C, Segouin C, Ceggid Fernand Widal Saint-Louis Checkpoint, Hôpitaux Universitaires Saint-Louis Lariboisière Fernand Widal, Association Aremedia, Association PASTT, Paris, France. La PrEP hors les murs : retour d'une expérience d'un CeGIDD Parisien en 2017 avec une association Transgenre. AFRAVIH. 2018 Avril 04, Bordeaux, France.

21.  Tokolo MH, Dimi S, Zucman D, Allbucher D. Accompagner les femmes migrantes en difficulté dans leur parcours de santé et éviter les ruptures de soins. SFLS. 2018 Octobre, Reims, France.

22.   Wastiaux A, Levine M, Viard J-P, Matheron S, Girard T. Adolescents et jeunes adultes VIH + infectés par transmission mere-enfant : 10 ans d’un modèle de transition en unité hospitalière ambulatoire. 19ème JNI. 2018 Juin, Nantes, France.

Date de dernière mise à jour : 24 juin 2019